-
Mashup Score: 0Retrospective Study Suggests Large Proportion of EU-Approved Oncology Drugs Offer Minimal or No Added Benefit - 2 month(s) ago
Most oncology drugs approved by the EMA recover research and development costs within a few years, even if the drug is providing little added benefit.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Retrospective Study Suggests Large Proportion of EU-Approved Oncology Drugs Offer Minimal or No Added Benefit - 2 month(s) ago
Most oncology drugs approved by the EMA recover research and development costs within a few years, even if the drug is providing little added benefit.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet-
Retrospective Study Suggests Large Proportion of EU-Approved Oncology Drugs Offer Minimal or No Added Benefit @UniUtrecht @bmj_latest #global #oncology https://t.co/mJlEnosg5X
-
-
Mashup Score: 0Retrospective Study Suggests Large Proportion of EU-Approved Oncology Drugs Offer Minimal or No Added Benefit - 2 month(s) ago
Most oncology drugs approved by the EMA recover research and development costs within a few years, even if the drug is providing little added benefit.
Source: www.onclive.comCategories: General Medicine News, Onc News and JournalsTweet-
Retrospective Study Suggests Large Proportion of EU-Approved Oncology Drugs Offer Minimal or No Added Benefit @UniUtrecht @bmj_latest #global #oncology https://t.co/mJlEnosg5X
-
-
Mashup Score: 28How ASCO’s Regional Councils Are Having an International Impact on Patients With Cancer - The ASCO Post - 2 month(s) ago
In September 2023, ASCO announced the establishment of its fourth regional council, the Central and Eastern European Regional Council, which includes representatives from 17 countries, with the goal of expanding ASCO’s missi on globally to “conquer cancer through research, education, and promotion of the highest-quality, equitable patient care.” This latest council has representatives from Albania, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Estonia, Greece, Hungary, Lithuania, Montenegro,
Source: ascopost.comCategories: General Medicine News, Onc News and JournalsTweet-
How ASCO’s Regional Councils Are Having an International Impact on Patients With Cancer: A Conversation With Julie Gralow, MD, FACP, FASCO, and Doug Pyle https://t.co/aRccJSUy2J #GlobalOncology @ASCO @jrgralow
-
-
Mashup Score: 36BLOG: ‘Exciting’ discoveries at oncology conferences not always accessible to everyone - 3 month(s) ago
I am a medical oncologist from Mexico City and my main practice is at an academic institution where we mostly focus on patients with breast cancer. However, like many oncologists in Mexico, I also have some private practice where I see patients with all cancer types.Since becoming an oncologist, every time I attend a conference and witness a new positive study about a novel treatment that
Source: www.healio.comCategories: General Medicine News, Hem/OncsTweet-
Dr @hafaydeefe writes about the gap between her excitement for new treatments presented at medical conferences 🥳 and the waiting to discover if and when she can actually provide those tx to her patients in Mexico⏱️ 🇲🇽 #globalOncology @OncoAlert 👉https://t.co/nrVIACPj2W https://t.co/P14GaFGRFm
-
-
Mashup Score: 71Cross-border utilization of cancer care by patients in the US and Mexico – a survey of Mexican oncologists - Globalization and Health - 6 month(s) ago
Background The US-Mexico border is the busiest in the world, with millions of people crossing it daily. However, little is known about cross-border utilization of cancer care, or about the reasons driving it. We designed a cross sectional online survey to understand the type of care patients with cancer who live in the US and Mexico seek outside their home country, the reasons why patients traveled across the border to receive care, and the barriers faced when seeking cross-border care. Results The online survey was sent to the 248 cancer care providers working in the six Mexican border states who were registered members of the Mexican Society of Oncology. Responses were collected between September-November 2022. Sixty-six providers (response rate 26%) completed the survey. Fifty-nine (89%) reported interacting with US-based patients traveling to Mexico to receive various treatment modalities, with curative surgery (n = 38) and adjuvant chemotherapy (n = 31) being the most common. Fort
Source: link.springer.comCategories: General Medicine News, Oncologists2Tweet-
If you want a good #globaloncology read for the weekend check out our paper on the cross-border utilization of cancer care in the US 🇺🇸 and Mexico 🇲🇽 led by @MichaelLaPelusa @FernandoDiazMD1 and @hafaydeefe Available free in @GHJournal 👇👇👇 https://t.co/lOVc5GMS0b https://t.co/xiw9o5Br6b
-
-
Mashup Score: 1Disparities in Cancer Control in Central America and the Caribbean - 8 month(s) ago
Author links open overlay panel Anne Christine Buteau MD a, Alicia Castelo-Loureiro MD b, Regina Barragan-Carrillo MD c, Suyapa Bejarano MD d, Alba J. Kihn-Alarcón MD, MSc e, Enrique Soto-Perez-de-Celis MD, PhD f • Central America and the Caribbean is a highly heterogeneous region with an increasing burden of cancer facing many challenges for providing equitable access to high-quality cancer care. • Barriers for obtaining cancer care across the region include socioeconomic barriers, health-care system
Source: www.sciencedirect.comCategories: Latest Headlines, Oncologists2Tweet-
@alicastletree @AnneChr41185205 @ReginaBarCar @ClinicReviews @ElsevierConnect We also provide some key points for guiding policy makers aiming at decreasing cancer control disparities in the region #Latam #Globonc #Globaloncology 👇👇👇👇👇👇👇 https://t.co/JWZNbU41xf https://t.co/13ktm48cp4
-
In the manuscript, we discuss disparities in countries in Central America and the Caribbean, including health system challenges and local initiatives aimed at reducing them #globaloncology #globonc https://t.co/JWZNbU41xf https://t.co/I6PUnS06sc
-
Our manuscript on Cancer Control in Central America and the Caribbean #Latam #Caribbean is online and free to read in @ClinicsReviews Just follow this link 👇👇👇👇👇 https://t.co/JWZNbU41xf @AnneChr41185205 @alicastletree @ReginaBarCar @ajchgt https://t.co/XoXh6TfSab
-
-
Mashup Score: 0
Syrian migrants, including refugees, may be more likely to be diagnosed with a more advanced stage of breast cancer at a younger age when compared with individuals from Jordan, according to a recent study published by Hazra et al in JAMA Network Open. The new findings suggest the trauma associated with forced displacement may contribute to these cancer disparities. War and other conflicts are capable of impacting individuals’ health in ways that extend far beyond the active combat zone. Prior to the
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Forced Displacement and Diagnosis of Cancer in Syrian Refugees https://t.co/QAaRfIfbkU #cancer #refugees #globaloncology
-
-
Mashup Score: 1Rwandas Vision for Increasing Cervical Cancer Prevention One Village at a Time - The ASCO Post - 10 month(s) ago
Cervical cancer is a serious problem in many low- and middle-income countries such as the African country of Rwanda. Although the cervical cancer rate in Rwanda remains more than twice the U.S. rate, there has been improvement in recent years that cancer research organizations can learn from to help other countries reduce their rates. Regine Nshimiyimana Maniraho, DNP, PharmB, AOCNP In their…
Source: ascopost.comCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Regine Nshimiyimana Maniraho, DNP, PharmB, AOCNP on Rwanda’s Vision for Increasing Cervical Cancer Prevention One Village at a Time https://t.co/gC46nA4pxD #gyncsm #cervicalcancer #Rwanda #globaloncology
-
-
Mashup Score: 0UAB Libraries EZProxy Login - 11 month(s) ago
BlazerID Login Current UAB students, faculty and staff, click below to… Login using your Blazer ID UA/UAH Joint Enrollment Login For UA and UAH Joint Enrollment, click below to… Login using your myBama ID Login using your Charger ID Off-campus access to library resources is limited to current UAB students, faculty, and staff.
Source: login.uab.idm.oclc.orgCategories: Hem/Oncs, Latest HeadlinesTweet-
While there is a spotlight on global drug pricing its important to note! 🛑 complex process 🛑health economics/ policy should be mandatory part of GME 🛑 multiple stakeholders involved https://t.co/DiTRHIuAcr… #oncmeded #globaloncology #Equity https://t.co/ShGmJxIlaU
-
Retrospective Study Suggests Large Proportion of EU-Approved Oncology Drugs Offer Minimal or No Added Benefit @UniUtrecht @bmj_latest #global #oncology https://t.co/mJlEnosg5X